KR960700710A - 항종양 조성물 및 치료방법(antitumor compositions and methods of treatment) - Google Patents

항종양 조성물 및 치료방법(antitumor compositions and methods of treatment) Download PDF

Info

Publication number
KR960700710A
KR960700710A KR1019950703798A KR19950703798A KR960700710A KR 960700710 A KR960700710 A KR 960700710A KR 1019950703798 A KR1019950703798 A KR 1019950703798A KR 19950703798 A KR19950703798 A KR 19950703798A KR 960700710 A KR960700710 A KR 960700710A
Authority
KR
South Korea
Prior art keywords
compound
alkyl
pharmaceutically acceptable
hydrogen
nco
Prior art date
Application number
KR1019950703798A
Other languages
English (en)
Inventor
제랄드 부르(사망) 그룬디
코라 슈우 그로스만
제임스 제프리 하우버트
제임스 에드워드 레이
존 엘돈 토쓰
Original Assignee
피터 지. 스트링거
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터 지. 스트링거, 일라이 릴리 앤드 캄파니 filed Critical 피터 지. 스트링거
Publication of KR960700710A publication Critical patent/KR960700710A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 특정 인돌린설폰아미드 및 치환된-인돌설폰아미드 유도체 및 포유동물에서의 감수성 종양을 치료하는데 이들을 사용하는 방법을 제공한다. 또한 담체, 부형제 또는 희석제와 혼합 형태로 이러한 인돌린설폰아미드 및 치환된-인돌린설폰아미드 유도체를 사용하는 특정 신규한 약학 제형을 제공한다.

Description

향종양 조성물 및 치료방법(ANTITUMOR COMPOSITIONS AND METHODS OF TREATMENT)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 하기 일반식의 화합물 또는 그의 약학적으로 허용되는 염 또는 용매화물 :
    R1은 C1-C6알킬이며; R2및 R3는 수소, 할로, C1-C6알킬, 및 트리플루오로메틸로 이루어진 그룹중에서 독립적으로 선택되나, 단 R2및 R3중 하나만이 수소일 수 있다.
  2. 제1항에 있어서, 상기 A가
    화합물.
  3. 제2항에 있어서, N-[[3,4-디클로로페닐)아미노]카보닐]-1-메틸-1H-인돌-5-설폰아미드 또는 그의 약학적으로 허용되는 염 또는 용매화물인 화합물.
  4. 제1항에 있어서, 상기 A가
    화합물.
  5. 제4항에 있어서, N-[[3,4-디클로로페닐)아미노]카보닐]-2,3-디하이드로-1H-인돌-5-설폰아미드, N-[[4-클로로페닐)아미노]카보닐]-2,3-디하이드로-1H-인돌-5-설폰아미드 또는 그의 약학적으로 허용되는 염 또는 용매화물인 화합물.
  6. 활성 성분으로서 제1 내지 제5항중 어느 한항에 청구된 화합물 또는 그의 약학적으로 허용되는 염 또는 용매화물을 이를 위한 하나 이상의 약학적으로 허용되는 담체, 희석제 또는 부형제와 함께 포함하는 약학 제형.
  7. 항암제로서 사용하기 위한 제1 내지 제5항중 어느 한항에 청구된 화합물 또는 그의 약학적으로 허용되는 염 또는 용매화물.
  8. 하기 일반식(1) 화합물과 하기 일반식(2)의 설포닐 화합물을 반응시킴을 포함하는, 제1 내지 제5항중 어느 한항에 청구된 바와 같은 설포닐우레아의 제조 방법 :
    R1은 C1-C6알킬이며; R2및 R3는 수소, 할로, C1-C6알킬, 및 트리플루오로메틸로 이루어진 그룹중에서 독립적으로 선택되나, 단 R2및 R3중 하나만이 수소일 수 있고; X는 -NCO, -NH2또는 -NH-COORaC1-C6알킬이다)이나 단, X가 -NCO 또는 -NH-COORa이면, Y는 -NH2이고, X가 -NH2이면 Y는 -NCO이며; Y는 -NH2또는 -NCO이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950703798A 1993-03-10 1994-03-10 항종양 조성물 및 치료방법(antitumor compositions and methods of treatment) KR960700710A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2909593A 1993-03-10 1993-03-10
US08/029,095 1993-03-10
PCT/US1994/002606 WO1994020101A1 (en) 1993-03-10 1994-03-10 Antitumor compositions and methods of treatment

Publications (1)

Publication Number Publication Date
KR960700710A true KR960700710A (ko) 1996-02-24

Family

ID=21847185

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950703798A KR960700710A (ko) 1993-03-10 1994-03-10 항종양 조성물 및 치료방법(antitumor compositions and methods of treatment)

Country Status (20)

Country Link
EP (1) EP0614887B1 (ko)
JP (1) JPH08507532A (ko)
KR (1) KR960700710A (ko)
AT (1) ATE154345T1 (ko)
AU (1) AU687042B2 (ko)
BR (1) BR9405997A (ko)
CA (1) CA2157801A1 (ko)
CZ (1) CZ232695A3 (ko)
DE (1) DE69403695T2 (ko)
DK (1) DK0614887T3 (ko)
ES (1) ES2102774T3 (ko)
FI (1) FI954213A (ko)
GR (1) GR3023827T3 (ko)
HU (1) HU218660B (ko)
NO (1) NO953557L (ko)
NZ (1) NZ263080A (ko)
PL (1) PL310558A1 (ko)
RU (1) RU2127259C1 (ko)
WO (1) WO1994020101A1 (ko)
ZA (1) ZA941500B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69708340T2 (de) * 1996-08-22 2002-05-16 Dong Wha Pharm Ind Co Ltd Arylsulfonylimidazolon-derivate als antitumormittel
DE19919793A1 (de) 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
US7282595B2 (en) 2002-11-22 2007-10-16 Eli Lilly And Company Antitumor benzoylsulfonamides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
HUT72897A (en) 1996-06-28
EP0614887A1 (en) 1994-09-14
FI954213A0 (fi) 1995-09-08
CA2157801A1 (en) 1994-09-15
BR9405997A (pt) 1995-12-19
RU2127259C1 (ru) 1999-03-10
PL310558A1 (en) 1995-12-27
FI954213A (fi) 1995-10-11
WO1994020101A1 (en) 1994-09-15
AU687042B2 (en) 1998-02-19
NO953557L (no) 1995-11-02
NO953557D0 (no) 1995-09-08
NZ263080A (en) 1996-12-20
ZA941500B (en) 1995-09-04
ES2102774T3 (es) 1997-08-01
ATE154345T1 (de) 1997-06-15
DE69403695D1 (de) 1997-07-17
JPH08507532A (ja) 1996-08-13
EP0614887B1 (en) 1997-06-11
DK0614887T3 (da) 1997-10-20
HU218660B (hu) 2000-10-28
GR3023827T3 (en) 1997-09-30
DE69403695T2 (de) 1997-10-30
AU6363894A (en) 1994-09-26
CZ232695A3 (en) 1996-01-17
HU9502627D0 (en) 1995-11-28

Similar Documents

Publication Publication Date Title
KR930019655A (ko) 종양치료 조성물 및 치료방법
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
CA2203618A1 (fr) Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR950017949A (ko) 벤조티오펜 화합물과 수용성 사이클로덱스트린의 수용성 내포착물, 및 그의 약학제제 및 제조 방법
NO800447L (no) Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser
KR960007592A (ko) 신규한 피롤로카바졸
HUP0104033A2 (hu) Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk
KR930017885A (ko) 항종양 조성물 및 종양의 치료방법
HUT56089A (en) Process for producing quinazoline derivatives and pharmaceutical compositions containing them
KR960041178A (ko) 신규의 퀴나졸린 화합물 및 활성 성분으로서 이를 함유하는 항종양제
KR960700710A (ko) 항종양 조성물 및 치료방법(antitumor compositions and methods of treatment)
KR950032183A (ko) 글루코피라노사이드 벤조티오펜
DE69330601D1 (de) Serotoninergische ergolin derivate
ATE716T1 (de) Cytostatisch wirkende arzneimittel bzw. pharmazeutische zubereitungen.
MX9206930A (es) Nuevos compuestos
SE8802066D0 (sv) N-imidazolyl derivatives of bicyclic compounds useful in medicine
EA200100725A2 (ru) Новые бензотиадиазиновые соединения, способ их получения и их содержащие фармацевтические композиции
KR930000499A (ko) 티옥산테논 항종양제
FR2793248B1 (fr) Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO932549L (no) Nye, ikke ioniske ioderte roentgenkontrastmidler, fremgangsmaater for deres fremstilling og galenioniske preparater som inneholder dem
RU95122639A (ru) Противоопухолевые композиции и способы применения их для лечения
CA2213054A1 (fr) Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE96144T1 (de) 2-aminoacetamid derivate.
RU2002124771A (ru) Применение соединения для получения лекарственного препарата
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application